Abstract
Farnesyl- and geranylgeranylpyrophosphate (FPP and GGPP) are isoprenoid intermediates in the mevalonate pathway. They play a crucial role in cell survival, growth and differentiation due to their attachment (isoprenylation) to small GTPases (Ras, Rho, etc.). Isoprenoid formation seems to be tightly regulated within the mevalonate pathway and its perturbation has been linked to certain diseases (e.g., cancer, Alzheimer’s disease), but tissue levels are unknown. It is therefore of the utmost importance to quantify these isoprenoids in diseased tissue or in tissue after drug administration. The current work describes an isolation procedure utilizing a combination of Extrelut® liquid/liquid and reversed-phase solid-phase extraction (SPE) for homogenized human frontal cortex tissue. In addition, after a careful validation of an HPLC–fluorescence method, this assay allowed the determination of nanomolar concentrations of endogenous FPP and GGPP levels (4.5 and 10.6 ng/mg protein, respectively) in human brain tissue. The method is selective, precise (<15% RSD), accurate (<15% relative error) and sensitive over a linear range of 10–400 ng/mL for FPP and 50–1000 ng/mL for GGPP according to the current FDA criteria for bioanalytical method validation. Overall, this new method introduces the ability to simultaneously quantify FPP and GGPP in human brain tissue, and is potentially applicable to several other tissues and species.
Similar content being viewed by others
References
McTaggart SJ (2006) Cell Mol Life Sci 63:255–267
Calleros L, Lasa M, Rodriguez-Alvarez FJ, Toro MJ, Chiloeches A (2006) Apoptosis 11:1161–1173
Liao JK (2002) J Clin Invest 110:285–288
Buhaescu I, Izzedine H (2007) Clin Biochem 40:575–584
Cole SL, Vassar R (2006) Neurobiol Dis 22:209–222
Motoshima H, Goldstein BJ, Igata M, Araki EJ (2006) Physiol 574:63–71
Duncan RE, El-Sohemy A, Archer MC (2005) Mol Nutr Food Res 49:93–100
Brunner TB, Hahn SM, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ (2003) Cancer Res 63:5656–5668
Barnidge DR, Dratz EA, Martin T, Bonilla LE, Moran LB, Lindall A (2003) Anal Chem 75:445–451
Downard J (2003) Nat Rev Cancer 3:11–22
Sahai E, Marshall CJ (2003) Nat Rev Cancer 2:133–142
Farooqui AA, Ong WY, Horrocks LA, Chen P, Farooqui T (2007) Brain Res Rev 56:443–471
Eckert GP, Müller WE, Wood WG (2007) Future Lipidol 2:423–432
Bruenger E, Rilling HC (1988) Anal Biochem 173:321–327
Saisho Y, Morimoto A, Umeda T (1997) Anal Biochem 252:89–95
Tong H, Holstein SA, Hohl RJ (2005) Anal Biochem 336:51–59
Tong H, Wiemer AJ, Neighbors JD, Hohl RJ (2008) Anal Biochem 378(2):138–143
Adair WL, Cafmeyer N, Keller RK (1984) J Biol Chem 7:4441–4446
CDER (2001) Guidance for industry: bioanalytical method validation. Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Rockville, MD (see http://www.fda.gov/cder/guidance/4252fnl.pdf, last accessed 25 July 2008)
Naasner M, Mergler M, Wolf K, Schuphan I (2001) J Chromatogr A 945:133–138
Appels NM, Rosing H, Stephens TC, Schellens JH, Beijnen JH (2006) Anal Chem 78:2617–2622
Cordle A, Koenigsknecht-Talboo J, Wilkinson B, Limpert A, Landreth GJ (2005) Biol Chem 280:34202–32409
Dursina B, Reents R, Delon C, Wu Y, Kulharia M, Thutewohl M, Veligodsky A, Kalinin A, Evstifeev V, Ciobanu D, Szedlacsek SE, Waldmann H, Goody RS, Alexandrov K (2006) J Am Chem Soc 128:2822–2835
Jemal M, Ouyang Z, Powell ML (2002) Rapid Commun Mass Spectrom 16:1538–1547
Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, Shah VP, Skelly JP, Swann PG, Viswanathan RW (2007) Pharm Res 24:1962–1973
Jemal M, Schuster A, Whigan DB (2003) Rapid Commun Mass Spectrom 17:1723–1734
Li W, Cohen LH (2003) Anal Chem 75:5854–5859
Acknowledgments
We would like to thank the Hanna Bragard-Apfel Foundation, the L.A. Brain Bank, and the Medical Research Council, as well as to acknowledge the provision of NIH grants AG23524, AG18357 and the support of the Department of Veterans Affairs. We also appreciate the technical support of Rambod Daneshfar.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hooff, G.P., Volmer, D.A., Wood, W.G. et al. Isoprenoid quantitation in human brain tissue: a validated HPLC–fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP). Anal Bioanal Chem 392, 673–680 (2008). https://doi.org/10.1007/s00216-008-2306-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-008-2306-3